Advertisement

Topics

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD).

08:00 EDT 1st June 2018 | BioPortfolio

Summary of "Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)."

This European multicenter study aimed to elucidate suicidality in major depressive disorder. Previous surveys suggest a prevalence of suicidality in major depressive disorder of ≥50%, but little is known about the association of different degrees of suicidality with socio-demographic, psychosocial, and clinical characteristics.

Affiliation

Journal Details

This article was published in the following journal.

Name: The international journal of neuropsychopharmacology
ISSN: 1469-5111
Pages: 539-549

Links

DeepDyve research library

PubMed Articles [50903 Associated PubMed Articles listed on BioPortfolio]

Mediation Analyses of Insight, Quality of Life, Depression, and Suicidality: Results From the FACE-SZ Cohort.

The relationship between greater insight and increased risk of suicide in patients with schizophrenia is debated. The purpose of this study was to assess whether quality of life (QoL) and depression m...

Efficacy of extended clinical management, group CBT, and group plus individual CBT for major depression: Results of a two-year follow-up study.

Cognitive therapy has gained prominence in the treatment of major depression, however, little is known about its long-term benefits when delivered during inpatient treatment or combined with outpatien...

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study.

Clinical variables were investigated in the 'treatment resistant depression (TRD)- III' sample to replicate earlier findings by the European research consortium 'Group for the Study of Resistant Depr...

Anxiety Symptoms in Older Adults with Depression Are Associated with Suicidality.

Anxiety symptoms are common in older adults with depression, but whether severe anxiety is associated with poorer outcomes of depression is unknown. The objective of the present study was to examine t...

Chronotype and suicide: The mediating effect of depressive symptoms.

Chronotype is individual characteristic, and people who stay up late are acknowledged to be more likely to experience depressive symptoms as well as impulsivity and suicide. Depression is also associa...

Clinical Trials [14264 Associated Clinical Trials listed on BioPortfolio]

Risperidone and Suicidality in Major Depressive Disorder

The purpose of this trial is to investigate the efficacy of risperidone as an adjunct to an antidepressant treatment in the acute management of suicidality during an episode of major depre...

Mastery, Social Support and Depression of Patients With Major Depression

The purpose of this study was to discuss the relation of mastery, social support and depression in patients with depressive disorder. Cross-sectional quantitive study and purposive samplin...

A Double-blind Study of Buprenorphine Treatment of Acute Suicidality

The acutely suicidal patient presents a complex and dangerous clinical dilemma. Many suicidal patients receive antidepressant medications, but the onset of action of these medications is a...

Ketamine in Borderline Personality Disorder

The purpose of this study is to test the potential of the rapid-acting anti-depressant ketamine to decrease suicidality in Borderline Personality Disorder (BPD). The rate of completed sui...

A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive Disorder

The study will evaluate the efficacy, safety, and tolerability of 450 milligrams (mg) of Rapastinel, compared to placebo in adult patients with major depressive disorder (MDD) who are at i...

Medical and Biotech [MESH] Definitions

Depression in POSTPARTUM WOMEN, usually within four weeks after giving birth (PARTURITION). The degree of depression ranges from mild transient depression to neurotic or psychotic depressive disorders. (From DSM-IV, p386)

The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.

Depressive states usually of moderate intensity in contrast with major depression present in neurotic and psychotic disorders.

A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. (From AMA Drug Evaluations Annual, 1994, p311)

An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Mental Health
Adhd Anorexia Depression Dyslexia Mental Health Psychiatry Schizophrenia Stress Mental health, although not being as obvious as physical health, is very important, causing great unhappiness to those affected, causing add...


Searches Linking to this Article